Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue July 2014
 •  Sealed Air Moves HQ  •  Style & Appearance On a Global Scale  •  Scientific Skin Care  •  Envy Expands Into Brazil  •  Private Equity Firm Invests in Butter London
Print

Galderma Acquires Spirig



Published January 25, 2013
Related Searches: dermatology damage medical skin
Post a comment
SWITZERLAND: Galderma Pharma S.A, the L’Oréal owned global specialty pharmaceutical company focused on dermatology, has acquired dermatological products producer Spirig.

Spirig’s products treat conditions such as solar damage and skin barrier function impairment. In addition, the company has a range of medically-proven products that prevent pre-cancerous conditions, such as actinic keratosis, a type of non-melanoma skin cancer. Leading brands include Excipial, Daylong and Daylong Actinica. Based in Egerkingen, Spirig is the leader in dermatology in Switzerland. With 390 employees, Spirig generated sales of approximately $105 million in 2011.


blog comments powered by Disqus